Skip to content
★ Sign in to follow
LL

Langdon L. Miller

Directeur Médical
Cleveland Biolabs Inc
Total declarations
1
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 23 Jul 2021 for Cleveland Biolabs INC, €25k.

Insider track record

Disclosed buys
0
Disclosed sells
0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Langdon L. Miller: trading record in brief

Langdon L. Miller has a single filing on record, published on 23 July 2021: an option exercise of €25k in Cytocom, Inc. One trade is not enough to describe a pattern. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Langdon L. Miller

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ◇
    Chief Medical OfficerExecutivesCleveland Biolabs Inc
    30,000 USD19SEC
    10,000 shares@ US$3.00100.0% of flowCommon Stock, par value $0.005 per shareSEC:0001437749-21-017452:0

1 of 1 declaration